SkyView Investment Advisors’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
2023
Q1
$728K Hold
2022
Q4
$717K Hold
2022
Q3
$719K Hold
2022
Q2
$710K Hold
2022
Q1
$706K Hold
2021
Q4
$701K Buy
2021
Q3
$650K Buy